Hurel Corporation's Series A - III Round

Hurel Corporation raised a round of funding on September 24, 2014.

Hurel Corporation is a world-leading provider of advanced liver tissue constructs and microfluidic cell-based assay platforms that are used in pre-clinical drug development by major pharmaceutical and…

Articles about Hurel Corporation's Series A - III Round: